
Inhaltsverzeichnis
Drugs for HER-2-positive Breast Cancer: A Major Approval for Translational Cancer Research (Maria Sibilia, Christoph C. Zielinski, Rupert Bartsch, Thomas Grunt). - The EGFR/ErbB family in breast cancer: from signaling to therapy (Wolfgang J. Köstler
and Yosef Yarden). - Trastuzumab as Adjuvant treatment for early stage HER-2 positive breast cancer (Rupert Bartsch
and Guenther G. Steger). - Trastuzumab Resistance in breast cancer (Floriana Morgillo, Michele Orditura, Teresa Troiani, Erika Martinelli, Ferdinando De Vita, Fortunato Ciardiello). - Treatment with Trastuzumab beyond Progression (Gunter von Minckwitz and Cristina Pirvulescu). - Pertuzumab a HER-2 dimerisation inhibitor for the treatment of breast and other cancers (Giulia Bianchi and Luca Gianni). - Beyond trastuzumab: Second generation targeted therapies for HER2--positive breast cancer (Flavio F. Solca, Guenther R. Adolf, Hilary Jones, Martina M. Uttenreuther-Fischer).
Es wurden noch keine Bewertungen abgegeben. Schreiben Sie die erste Bewertung zu "Drugs for HER-2-positive Breast Cancer" und helfen Sie damit anderen bei der Kaufentscheidung.